Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Kyriakides PW, Inghirami G. Are we ready to take full advantage of patient-derived tumor xenograft models? Hematol Oncol. 2018;36(1):24-27.

Saab J, Santos-Zabala ML, Loda M, Stack EC, Hollmann TJ. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi. Am J Dermatopathol. 2018;40(4):259-264.

Hata T, Suenaga M, Marchionni L, Macgregor-Das A, Yu J, Shindo K, et al. Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol. 2018;188(7):1723-1733.

Hsu JM, Artz A, Mayer SA, Guarner D, Bishop MR, Reich-Slotky R, et al. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2018;24(2):359-365.

Haas T, Cushing MM, Asmis LM. Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro. Scand J Clin Lab Invest. 2018;78(3):230-235.

Lange KR, Fischer C, Rajappa P, Connors S, Pisapia D, Greenfield JP, et al. Rapid autopsy of a patient with recurrent anaplastic ependymoma. Palliat Support Care. 2018;16(2):238-242.

Snow J, Mosquera JM, Scognamiglio T, Robinson BD, Khani F. A Precious Diagnostic "Pearl": The Necklace Pattern in Germ Cell Tumors of the Testis. Int J Surg Pathol. 2018;26(2):148-150.

Armenia J, Wankowicz SA, Liu D, Gao J, Kundra R, Reznik E, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018;50(5):645-651.

Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, et al. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nat Commun. 2018;9(1):741.

Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, et al. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018;31(5):690-704.